🇺🇸 FDA
Patent

US 8623614

Method for the recombinant production of magnetic nanoparticles

granted A61KA61K49/1824

Quick answer

US patent 8623614 (Method for the recombinant production of magnetic nanoparticles) held by Ludwig-Maximilians-Universitat Munchen expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ludwig-Maximilians-Universitat Munchen
Grant date
Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K49/1824